User:Tkadm30/Notebook/AKT1: Difference between revisions
From OpenWetWare
< User:Tkadm30 | Notebook
m (Yar moved page User:Etienne Robillard/Notebook/AKT1 to User:Tkadm30/Notebook/AKT1: Automatically moved page while renaming the user "Etienne Robillard" to "Tkadm30") |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
* https://www.ncbi.nlm.nih.gov/pubmed/17638387 | * https://www.ncbi.nlm.nih.gov/pubmed/17638387 | ||
* https://www.ncbi.nlm.nih.gov/pubmed/25698444 | * https://www.ncbi.nlm.nih.gov/pubmed/25698444 | ||
== AKT/GSK3 signaling in schizophrenia == | |||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304298/ AKT/GSK3 signaling pathway and schizophrenia] | |||
== Anti-cancer drug development == | == Anti-cancer drug development == | ||
Latest revision as of 14:57, 2 October 2018
AKT1 signaling and CREB regulate neural differentiation and proliferation in the hippocampus:
